Cargando…
Successful Implementation of Menstrual Cycle Biomarkers in the Treatment of Infertility in Polycystic Ovary Syndrome—Case Report
Polycystic ovary syndrome (PCOS) is the most common cause of anovulatory infertility. Absent, impaired, or rare ovulation induces progesterone deficiency in the luteal phase, which is a critical problem in PCOS. A usual pattern of progesterone administration from a fixed and arbitrary pre-determined...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9956032/ https://www.ncbi.nlm.nih.gov/pubmed/36833150 http://dx.doi.org/10.3390/healthcare11040616 |
_version_ | 1784894493049225216 |
---|---|
author | Kicińska, Aleksandra M. Stachowska, Aneta Kajdy, Anna Wierzba, Tomasz H. Maksym, Radosław B. |
author_facet | Kicińska, Aleksandra M. Stachowska, Aneta Kajdy, Anna Wierzba, Tomasz H. Maksym, Radosław B. |
author_sort | Kicińska, Aleksandra M. |
collection | PubMed |
description | Polycystic ovary syndrome (PCOS) is the most common cause of anovulatory infertility. Absent, impaired, or rare ovulation induces progesterone deficiency in the luteal phase, which is a critical problem in PCOS. A usual pattern of progesterone administration from a fixed and arbitrary pre-determined day of a menstrual cycle may preserve infertility but can easily be avoided. We present the case of a 29-year-old infertile woman who had been ineffectively treated for over two years. We introduced a line of therapy that was suited to her individual menstrual cycle by implementing biomarker recording. Supplementation based on a standardized observation of the basal body temperature (BBT) and cervical mucus stopped the vicious circle of absent ovulation and hyperandrogenism, restoring regular bleeding, ovulation cycles, and fertility. The implementation of a reliable fertility awareness method (FAM), accompanied by a standardized teaching methodology and periodic review of the observations recorded by the patient, validated through an ultrasound examination and plasma gonadotropins, estrogens, and progesterone concentrations, is key to achieving therapeutic success. The presented case is an example of a clinical vignette for many patients who have successfully managed to improve their fertility and pregnancy outcomes by applying the principles of a personalized treatment approach together with gestagens by recording their fertility biomarkers. |
format | Online Article Text |
id | pubmed-9956032 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-99560322023-02-25 Successful Implementation of Menstrual Cycle Biomarkers in the Treatment of Infertility in Polycystic Ovary Syndrome—Case Report Kicińska, Aleksandra M. Stachowska, Aneta Kajdy, Anna Wierzba, Tomasz H. Maksym, Radosław B. Healthcare (Basel) Case Report Polycystic ovary syndrome (PCOS) is the most common cause of anovulatory infertility. Absent, impaired, or rare ovulation induces progesterone deficiency in the luteal phase, which is a critical problem in PCOS. A usual pattern of progesterone administration from a fixed and arbitrary pre-determined day of a menstrual cycle may preserve infertility but can easily be avoided. We present the case of a 29-year-old infertile woman who had been ineffectively treated for over two years. We introduced a line of therapy that was suited to her individual menstrual cycle by implementing biomarker recording. Supplementation based on a standardized observation of the basal body temperature (BBT) and cervical mucus stopped the vicious circle of absent ovulation and hyperandrogenism, restoring regular bleeding, ovulation cycles, and fertility. The implementation of a reliable fertility awareness method (FAM), accompanied by a standardized teaching methodology and periodic review of the observations recorded by the patient, validated through an ultrasound examination and plasma gonadotropins, estrogens, and progesterone concentrations, is key to achieving therapeutic success. The presented case is an example of a clinical vignette for many patients who have successfully managed to improve their fertility and pregnancy outcomes by applying the principles of a personalized treatment approach together with gestagens by recording their fertility biomarkers. MDPI 2023-02-18 /pmc/articles/PMC9956032/ /pubmed/36833150 http://dx.doi.org/10.3390/healthcare11040616 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Case Report Kicińska, Aleksandra M. Stachowska, Aneta Kajdy, Anna Wierzba, Tomasz H. Maksym, Radosław B. Successful Implementation of Menstrual Cycle Biomarkers in the Treatment of Infertility in Polycystic Ovary Syndrome—Case Report |
title | Successful Implementation of Menstrual Cycle Biomarkers in the Treatment of Infertility in Polycystic Ovary Syndrome—Case Report |
title_full | Successful Implementation of Menstrual Cycle Biomarkers in the Treatment of Infertility in Polycystic Ovary Syndrome—Case Report |
title_fullStr | Successful Implementation of Menstrual Cycle Biomarkers in the Treatment of Infertility in Polycystic Ovary Syndrome—Case Report |
title_full_unstemmed | Successful Implementation of Menstrual Cycle Biomarkers in the Treatment of Infertility in Polycystic Ovary Syndrome—Case Report |
title_short | Successful Implementation of Menstrual Cycle Biomarkers in the Treatment of Infertility in Polycystic Ovary Syndrome—Case Report |
title_sort | successful implementation of menstrual cycle biomarkers in the treatment of infertility in polycystic ovary syndrome—case report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9956032/ https://www.ncbi.nlm.nih.gov/pubmed/36833150 http://dx.doi.org/10.3390/healthcare11040616 |
work_keys_str_mv | AT kicinskaaleksandram successfulimplementationofmenstrualcyclebiomarkersinthetreatmentofinfertilityinpolycysticovarysyndromecasereport AT stachowskaaneta successfulimplementationofmenstrualcyclebiomarkersinthetreatmentofinfertilityinpolycysticovarysyndromecasereport AT kajdyanna successfulimplementationofmenstrualcyclebiomarkersinthetreatmentofinfertilityinpolycysticovarysyndromecasereport AT wierzbatomaszh successfulimplementationofmenstrualcyclebiomarkersinthetreatmentofinfertilityinpolycysticovarysyndromecasereport AT maksymradosławb successfulimplementationofmenstrualcyclebiomarkersinthetreatmentofinfertilityinpolycysticovarysyndromecasereport |